6 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
for Cryptococcal ... and Maintenance Therapy ... Recommendations for Cryptococcal ... Recommendations for Cryptococcal ... Recommendations for Cryptococcal
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... year B-III #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
Rare Invasive Yeasts - Species and Antifungal Therapy

Cryptococcus, 
Geotrichum, 
Kodamaea, 
(Pichia)ohmeri, 
Malassezia, 
Pseudozyma, 
Rhodotorula, 
Saccharomyces, 
Saprochaete
and Antifungal Therapy ... Cryptococcus ... Yeasts #Antifungal #Therapy ... #Management #Table
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... and maintenance therapy ... Induction Therapy ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... AI) Preferred Therapy ... please refer to Table ... Mycobacterium #AviumComplex ... #MAC #IDSA #Prevention